My laboratory focuses on the therapeutic applications of nanoparticle-based gene therapy, hyaluronan-cisplatin nanoparticle chemotherapy, the angiotensin II type 2 receptor (AT2R), and umbilical cord matrix stem cells for multiple organ type cancers.
“Our team studies tumor physiology, cytotherapy using umbilical cord-matrix stem cells and prevention of metastasis of malignant cancers to the lung and peritoneal cavity by nanoparticle-based gene delivery. We also study the relationship between angiotensin II receptor expression and cancer.”
Research Interests:
- Cancer is one of the most devastating diseases in the world and is the second leading cause of death in the United States
Research:
- Anatomy & Physiology – Studies tumor physiology, cytotherapy and prevention of metastasis to the lung and peritoneal cavity
Expertise:
- Anatomy & Physiology - Studies cancer cell-targeted nanoparticle-based gene therapy, stem cell and diet-based alternative medicine for cancer therapy
Keywords: Mesenchymal stem cells, stem-cell-based cancer-targeted therapy, gene therapy
Area of Expertise:
- Cell Signaling
- Cell migration and cell-to-cell contact
- Cell, Tissue, and Organ Development
- Stem cell biotechnology/physiology/regenerative medicine for injuries and disorders
- Cancer biology and tumor development
- Nanomedicine
- Biological interactions with nanoparticles
